Kenyans are first in Africa to get generic version of latest Aids drug

The brand name version of DTG is Tivicay, produced by ViiV Healthcare, which is majority-owned by GlaxoSmithKline. PHOTO | FILE

The government and Unitaid - a global health agency - have today announced the introduction of a new first-line generic version of the latest drug for people living with HIV/Aids, making Kenya the first African country to do so.

The drug can improve and prolong the lives of tens of thousands of people who suffer severe side effects and resistance to other treatments.

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.